UK Probes Genetic Link Between Obesity Drugs and Pancreas Damage
The UK is asking patients whose pancreas became dangerously inflamed after taking obesity drugs like Wegovy and Zepbound to come in for tests to understand whether there's a genetic risk for the condition.
The country's drug regulator, alongside Genomics England, is investigating whether a person's genetics might make them more vulnerable to acute pancreatitis — a potential serious side effect of Novo Nordisk A/S and Eli Lilly & Co. 's blockbusters.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
36 minutes ago
- Yahoo
Womb lining test offers miscarriage hope to women
UK scientists say they have developed a test which can help identify women with an abnormal womb lining that increases their risk of miscarriage. They say their work could pave the way for new treatments for those going through repeated pregnancy loss. In some women with a history of miscarriage, the womb lining doesn't react the way it should - transforming into a supportive place for the embryo to implant, the Warwick University team discovered. Charities say the findings could help provide an explanation, in some cases, for the trauma and devastation of recurrent miscarriage. Around one in six of all pregnancies are lost, most before twelve weeks, and each miscarriage increases the risk of another one happening. To date, most research in this area has focused on the quality of the embryo, with much less known about the role of the womb lining. Dr Jo Muter, study author and researcher at Warwick Medical School, said: "Many women are told they've just had 'bad luck', but our findings show that the womb itself may be setting the stage for pregnancy loss, even before conception takes place." The job of the womb lining is to receive the embryo and help it develop during pregnancy, thanks to a reaction which converts cells into a different, supportive state. But when that reaction is messed up and doesn't fully happen, the risk of bleeding and early pregnancy rises. Once a woman has had one faulty reaction, she is more likely to have another, the researchers say. They've developed a new test which can measure signs of a healthy or defective reaction in the womb lining, which is being piloted to help more than 1,000 patients at Tommy's National Centre for Miscarriage Research at University Hospital Coventry & Warwickshire (UHCW). Charlie Beattie, 37, had countless early miscarriages over the course of four years, to the point where "a positive pregnancy test wasn't exciting any more", she says. She and her husband Sam, from Leamington Spa, felt devastated and resigned to considering other options for having a family. Then they found out about at a trial taking place at the miscarriage research centre. Charlie had a sample of her womb taken, and the new test showed it was not "hospitable for babies", she says. After taking the drug sitagliptin for three months, she had a pregnancy which finally stuck - and nine-week-old June is the joyful result. "She's a tiny miracle. It doesn't feel real," says Charlie. She admits being anxious all the way through her pregnancy until June was safely in her arms. Even the pregnancy scans were a new experience. "We'd never seen anything on a scan before that moved," she says. "When they said 'I can see it, it's in the right place', we both burst into tears." Anyone can refer themselves to the clinic, but it has a long waiting list and funding issues mean patients must contribute to the cost of the test. Dr Jyotsna Vohra, director of research at Tommy's, said care and treatment for those who experience pregnancy or baby loss varied unacceptably across the UK. "There should be no barriers to accessing any test or treatment that has been proven to make a difference. "We hope NHS decision-makers will look carefully at the results of the Coventry pilot project and consider rolling this test out nationwide, so that everyone who might benefit has that opportunity." Dr Muter says the next step is to use the test to assess potential drug treatments. Sitagliptin, usually used to treat diabetes, is the go-to option for womb lining issues but there may be other existing drugs which can be repurposed, she added. With 80% of drugs not tested on pregnant women, it's unclear which ones might be effective.
Yahoo
2 hours ago
- Yahoo
Popular wellness trend is supposed to help with weight loss — but it may make you eat more
Maybe it's better not to take the plunge. While the ostensible point of most wellness trends is to promote good physical and mental health — as opposed to purely shedding pounds — weight management is often an added perk. But a fascinating new study published in the journal Physiology & Behavior warns that the caloric dump of one popular practice might be mostly in your head. Cold plunges and ice baths have made quite the splash in recent years, thanks to their purported boost in mental clarity, blood circulation and metabolism and their reduction in muscle soreness and stress. And if you've ever spent time in freezing water, you've probably noticed a significant uptick in your appetite — leading you to naturally believe you've really earned that burger. Sadly, it seems that might not be the case. Researchers suspect that the 'after-drop' effect — where core body temperature keeps falling after cold exposure, even when you're out of the water — triggers brain regions linked to temperature and energy, boosting appetite. 'Ice baths and cold dips have become really popular, with many people hoping they'll help with weight loss,' David Broom, a professor at UK's Coventry University Research Center for Physical Activity, Sport and Exercise Sciences, said in a statement. 'But our findings show that while cold water does make your body work harder and burn more energy, it also leads to eating more afterward — possibly undoing the potential weight-loss benefits,' he continued. 'Interestingly, people didn't say they felt hungrier during or after the cold water — they just ate more.' Researchers asked 10 men and five women who were active and healthy to spend 30 minutes in cold water (60 degrees Fahrenheit), hot water (95 degrees) or room temperature water (78 degrees). Afterwards — in what sounds like the best controlled trial ever — they were asked to eat a plate of pasta until 'comfortably full.' Of the three groups, the cold water cohort ate a whopping 240 extra calories. Depending on various factors, spending 30 minutes in a cold plunge — which is, by the way, not really recommended by experts, who advise shooting for no more than 10 minutes due to risk of hypothermia — only burns an estimated 250 to 500 calories, which is why probably why researchers say the overeating might negate the burn. For what it's worth, these findings align with what experts say about contrast therapy — the art of repeatedly alternating between hot and cold, like shvitzing in a sauna and then jumping into a cold plunge, as one does in modern bathhouses and traditional Finnish culture. Dr. Hany Demian, CEO of BioSpine and co-founder of Pain Care Clinics, previously told The Post that contrast therapy burns 'a very small amount of calories, but nothing significant.' He added that the surge in hunger has more to do with 'stomach contraction and relaxation, which stimulates the appetite.'
Digital Trends
2 hours ago
- Digital Trends
A hospital hack has been linked to a patient's death
Cyberattacks are troublesome at the best of times, but sometimes they can take a much darker turn. Case in point: Officials in the U.K. have just linked a ransomware attack to the death of a patient. Recommended Videos The attack, which took place in June 2024 and was widely reported at the time, targeted NHS blood services at hospitals and doctor's offices in London and disrupted more than 10,000 appointments. Following a special review of the patient's care conducted by the King's College Hospital NHS Foundation Trust, it was concluded that various factors had contributed to the patient's death, among them a lengthy wait for the result of a blood test — a wait arising from the disruption caused by the cyberattack. 'The patient safety incident investigation identified a number of contributing factors that led to the patient's death,' a spokesperson for the trust said in comments reported by the BBC, adding: 'This included a long wait for a blood test result due to the cyberattack impacting pathology services at the time.' The ransomware attack targeted pathology services provider Synnovis and was attributed to the Russia-based hacker group Qilin. The breach severely disrupted patient care, leading to the cancellation of more than 1,000 operations and outpatient appointments, and caused a critical shortage of O type blood in London hospitals. In addition to operational impacts, nearly 400GB of sensitive data — including patient names, NHS numbers, and blood test details — was stolen and published online. Qilin told the BBC that while it was 'sorry' for the harm caused, it did not accept blame. The group attempted to justify the attack as a political protest, claiming it was carried out in retaliation for the U.K. government's actions in a war that it declined to name. Speaking to the Financial Times, Dr Saif Abed, a former NHS doctor and specialist in cyber security and public health, described the patient's death as 'the tip of the iceberg,' claiming that it's 'a near certainty' that there have been similar deaths over the years but not recorded as such 'due to a lack of official investigations.' Abed added that an independent inquiry into NHS security and patient safety should begin as soon as possible. It's not the first time that a cyberattack has been cited as a contributing factor in a patient's death. In a tragic incident in 2022, a ransomware attack encrypted the servers at Düsseldorf University Clinic in Germany, forcing the transfer of a critically ill woman to another hospital 20 miles away. She arrived an hour later but died soon after arriving there.
